Hypothalamic hamartomas (HHs) are tumors generally associated with isolated central precocious puberty (CPP). To our knowledge, we report a unique case of a girl with HH associated with CPP and growth hormone deficiency. This case highlights the complex interaction between HHs and the hypothalamic-pituitary-gonadal axis. It also emphasizes the value of close follow-up of growth velocity in these patients even after treatment of the CPP.
We gratefully acknowledge Dr. Christine St-Martin for her contribution to the interpretation of the MRI.
Conflict of interests statement
Funding source: No external funding was secured for this study.
Financial disclosure: The authors have no financial relationships relevant to this article to disclose.
Conflict of interests: The authors have no conflict of interests to disclose.
Authors’ contributions: Rousseau-Nepton drafted the initial manuscript and approved the final manuscript as submitted. Kaduri reviewed and revised the manuscript, contributed to the writing of the discussion and approved the final manuscript as submitted. Garfield critically reviewed the manuscript and approved the final manuscript as submitted. Krishnamoorthy critically reviewed the manuscript and approved the final manuscript as submitted.
1. Arita K, Kurisu K, Kiura Y, Iida K, Otsubo H. Hypothalamic hamartoma. Neurol Med-Chir 2005;45:221–31.Search in Google Scholar
2. Rousso IH, Kourti M, Papandreou D, Tragiannidis A, Athanasiadou F. Central precocious puberty due to hypothalamic hamartoma in a 7-month-old infant girl. Eur J Pediatr 2008;167:583–5.Search in Google Scholar
3. Maixner W. Hypothalamic hamartomas – clinical, neuropathological and surgical aspects. Child’s Nerv Syst 2006;22:867–73.Search in Google Scholar
4. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1587–609.Search in Google Scholar
5. Styne D. Puberty. In: Gardner DG, Shoback D, editors. Greenspan’s basic & clinical endocrinology, 9th ed. New York: McGraw-Hill, 2007:527–52.Search in Google Scholar
6. Heger S, Partsch CJ, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999;84:4583–90.Search in Google Scholar
7. Jaruratanasirikul S, Thaiwong M. Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand. J Pediatr Endocrinol Metab 2011;24:519–23.Search in Google Scholar
8. Chung EM, Biko DM, Schroeder JW, Cube R, Conran RM. From the radiologic pathology archives: precocious puberty: radiologic-pathologic correlation. Radiographics 2012;32:2071–99.Search in Google Scholar
9. Boyko OB, Curnes JT, Oakes WJ, Burger PC. Hamartomas of the tuber cinereum: CT, MR, and pathologic findings. AJNR Am J Neuroradiol 1991;12:309–14.Search in Google Scholar
10. Debeneix C, Bourgeois M, Trivin C, Sainte-Rose C, Brauner R. Hypothalamic hamartoma: comparison of clinical presentation and magnetic resonance images. Horm Res 2001;56:12–8.Search in Google Scholar
11. Saleem SN, Said AH, Lee DH. Lesions of the hypothalamus: MR imaging diagnostic features. Radiographics 2007;27:1087–108.Search in Google Scholar
12. Freeman JL, Coleman LT, Wellard RM, Kean MJ, Rosenfeld JV, et al. MR imaging and spectroscopic study of epileptogenic hypothalamic hamartomas: analysis of 72 cases. AJNR Am J Neuroradiol 2004;25:450–62.Search in Google Scholar
13. Barkovich AJ. Intracranial, orbital, and neck masses of childhood. In: Barkovich AJ, editor. Pediatric neuroimaging, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2005:573–603.Search in Google Scholar
14. Savas Erdeve S, Ocal G, Berberoglu M, Siklar Z, Hacihamdioglu B, et al. The endocrine spectrum of intracranial cysts in childhood and review of the literature. J Pediatr Endocrinol Metab 2011;24:867–75.Search in Google Scholar
15. Ladjouze A, Soskin S, Garel C, Jullien M, Naud-Saudreau C, et al. GH deficiency with central precocious puberty: a new rare disorder associated with a developmental defect of the hypothalamic-pituitary area. Eur J Endocrinol 2007;156:463–9.Search in Google Scholar
16. Feuillan P, Peters KF, Cutler GB Jr., Biesecker LG. Evidence for decreased growth hormone in patients with hypothalamic hamartoma due to Pallister-Hall syndrome. J Pediatr Endocrinol Metab 2001;14:141–9.Search in Google Scholar
17. Martin DD, Seeger U, Ranke MB, Grodd W. MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism. AJNR Am J Neuroradiol 2003;24:1177–80.Search in Google Scholar
18. Fodor M, Kordon C, Epelbaum J. Anatomy of the hypophysiotropic somatostatinergic and growth hormone-releasing hormone system minireview. Neurochem Res 2006;31:137–43.Search in Google Scholar
19. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752–62.Search in Google Scholar
20. Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB Jr. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab 1999;84:44–9.Search in Google Scholar
©2014 by Walter de Gruyter Berlin Boston